DK1888742T3 - Leverstamceller - Google Patents

Leverstamceller

Info

Publication number
DK1888742T3
DK1888742T3 DK06756297.5T DK06756297T DK1888742T3 DK 1888742 T3 DK1888742 T3 DK 1888742T3 DK 06756297 T DK06756297 T DK 06756297T DK 1888742 T3 DK1888742 T3 DK 1888742T3
Authority
DK
Denmark
Prior art keywords
cell lines
stem cells
cells
methods
markers
Prior art date
Application number
DK06756297.5T
Other languages
English (en)
Inventor
Benedetta Bussolati
Giovanni Camussi
Sanchez Maria Beatriz Herrera
Stefano Buttiglieri
Original Assignee
Fresenius Medical Care De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care De Gmbh filed Critical Fresenius Medical Care De Gmbh
Application granted granted Critical
Publication of DK1888742T3 publication Critical patent/DK1888742T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK06756297.5T 2005-05-26 2006-05-24 Leverstamceller DK1888742T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IT2005/000303 WO2006126219A1 (en) 2005-05-26 2005-05-26 Liver progenitor cells
PCT/IT2006/000391 WO2006126236A1 (en) 2005-05-26 2006-05-24 Liver progenitor cells

Publications (1)

Publication Number Publication Date
DK1888742T3 true DK1888742T3 (da) 2011-01-24

Family

ID=35462653

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06756297.5T DK1888742T3 (da) 2005-05-26 2006-05-24 Leverstamceller

Country Status (12)

Country Link
US (1) US9334479B2 (da)
EP (1) EP1888742B1 (da)
JP (1) JP5144505B2 (da)
CN (2) CN101228266B (da)
AT (1) ATE486126T1 (da)
BR (1) BRPI0613375B1 (da)
CA (1) CA2609523C (da)
DE (1) DE602006017833D1 (da)
DK (1) DK1888742T3 (da)
ES (1) ES2355327T3 (da)
PL (1) PL1888742T3 (da)
WO (2) WO2006126219A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781186B2 (en) * 2000-09-25 2010-08-24 The United States Of America As Represented By The Secretary Of The Army Screening methods using normal human liver cell line
PL1928519T3 (pl) 2005-08-26 2012-08-31 Univ Minnesota Decelularyzacja i recelularyzacja narządów i tkanek
AU2006328988B2 (en) * 2005-12-21 2012-08-02 Universite Catholique De Louvain Isolated liver stem cells
US20110104126A1 (en) * 2008-05-14 2011-05-05 Public University Corporation Yokohama City Univer Human Hepatic Stem Cell, Method for Preparation of the Same, Method for Induction of Differentiation of the Same, and Method for Utilization of the Same
PT2296672E (pt) 2008-06-11 2016-01-22 Fresenius Medical Care De Gmbh Meio condicionado de células progenitoras de fígado
CN102448476A (zh) * 2009-03-31 2012-05-09 明尼苏达大学董事会 器官和组织的脱细胞化和再细胞化
EP2333047A1 (en) * 2009-12-09 2011-06-15 Fresenius Medical Care Deutschland GmbH Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
EP2363136A1 (en) 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
US9719068B2 (en) 2010-05-06 2017-08-01 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
US8415149B2 (en) * 2010-05-06 2013-04-09 Gwo Xi Stem Cell Applied Technology Co., Ltd. Hepatic progenitor cells and uses thereof
AU2011295779B2 (en) 2010-09-01 2015-08-27 Regents Of The University Of Minnesota Methods of recellularizing a tissue or organ for improved transplantability
CA2825252C (en) 2011-01-25 2018-10-16 Universite Catholique De Louvain Compositions of an antithrombin activator and a thrombin inhibitor for use in cell transplantation
JP6034406B2 (ja) 2012-01-25 2016-11-30 ユニヴェルシテ カソリック ド ルーヴァンＵｎｉｖｅｒｓｉｔｅ Ｃａｔｈｏｌｉｑｕｅ Ｄｅ Ｌｏｕｖａｉｎ 細胞移植のための組成物および方法
US10073096B2 (en) * 2012-10-05 2018-09-11 Life Technologies Corporation Markers capable of distinguishing cell pluripotency and uses thereof
SG10201906304TA (en) 2013-03-15 2019-08-27 Miromatrix Medical Inc Use of perfusion decellularized liver for islet cell recellularization
US20160129047A1 (en) * 2013-07-05 2016-05-12 Université Catholique de Louvain Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders
BR112016013623B1 (pt) * 2013-12-16 2023-03-21 Fresenius Medical Care Deutschland Gmbh Método de preparação de uma estrutura de célula esferoide semelhante à ilhota pancreática cultivada artificialmente, e uso de uma estrutura de célula esferoide
CA2949834A1 (en) 2014-05-28 2015-12-03 James Macormack Wells Methods and systems for converting precursor cells into gastric tissues through directed differentiation
WO2015190522A1 (ja) * 2014-06-12 2015-12-17 国立大学法人京都大学 内胚葉性幹細胞の製造方法
JP6804438B2 (ja) 2014-10-17 2020-12-23 チルドレンズ ホスピタル メディカル センター 多能性幹細胞を使用するヒト小腸のｉｎ ｖｉｖｏモデル、並びにそれを作製、及び使用する方法
US20200377863A1 (en) 2016-02-10 2020-12-03 Wake Forest University Health Sciences Model system of liver fibrosis and method of making and using the same
MA45274A (fr) * 2016-03-02 2019-01-09 Univ Catholique Louvain Préparations améliorées de cellules progénitrices hépatiques adultes
CA3016641A1 (en) 2016-05-05 2017-11-09 Children's Hospital Medical Center Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same
ES2861650T3 (es) 2016-05-06 2021-10-06 Unicyte Ev Ag Portadores farmacéuticos que contienen miARN para su uso en el tratamiento de enfermedades fibróticas provocadas por hiperglucemia
EP3509651B1 (en) 2016-09-06 2022-12-28 Miromatrix Medical Inc. Use of resected liver serum for whole liver engineering
CN110062764A (zh) 2016-12-05 2019-07-26 儿童医院医学中心 结肠类器官及其制备和使用方法
EP3724334A1 (en) 2017-12-14 2020-10-21 Unicyte EV AG Pharmaceutical carriers containing mirnas for use in the treatment of renal cancer
WO2019197442A1 (en) 2018-04-12 2019-10-17 Unicyte Ev Ag A combination of active ingredients for the treatment of tumor
US20210238552A1 (en) 2018-08-10 2021-08-05 Unicyte Ev Ag Extracellular vesicles loaded with an exogenous molecule
WO2020035480A1 (en) 2018-08-16 2020-02-20 Unicyte Islet Ag Viable pancreatic islet-like cell structures and a method of preparing thereof
CN113966392A (zh) 2019-06-10 2022-01-21 联合细胞Ev股份公司 用于降低细胞衰老的来自人肝干细胞的胞外囊泡(hlsc-ev)
CN111394391B (zh) * 2019-07-11 2022-12-06 上海赛立维生物科技有限公司 肝祖细胞样细胞库的构建方法及其制备的细胞株与应用
EP3816276A1 (en) 2019-10-31 2021-05-05 Unicyte Islet AG Viable pancreatic islet-like cell structures and a method of preparing thereof
JP2023516484A (ja) 2020-03-11 2023-04-19 ビット バイオ リミテッド 肝細胞作製方法
CN113999876B (zh) * 2021-08-31 2023-09-05 四川大学华西医院 一种基于肝卵圆细胞恶性化的原发性小鼠肝癌模型及其建立方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129911A (en) 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
DE60040782D1 (de) 1999-01-19 2008-12-24 Univ North Carolina Menschliche leber-vorläuferzellen
US7456017B2 (en) * 1999-10-01 2008-11-25 University Of North Carolina At Chapel Hill Processes for clonal growth of hepatic progenitor cells
JP4344231B2 (ja) 2001-05-16 2009-10-14 財団法人神奈川科学技術アカデミー ｄｌｋを用いた未分化肝細胞の検出及び分離方法
EP1444345A4 (en) * 2001-10-18 2004-12-08 Ixion Biotechnology Inc TRANSFORMATION OF STEM CELLS AND LIVER PROGENITORS INTO FUNCTIONAL CELLS OF PANCREAS
JP2003208195A (ja) * 2002-01-16 2003-07-25 Sharp Corp 連続音声認識装置および連続音声認識方法、連続音声認識プログラム、並びに、プログラム記録媒体
IL164048A0 (en) * 2002-03-15 2005-12-18 Univ North Carolina Primitive and proximal hepatic stemcells
US20050074876A1 (en) * 2003-10-03 2005-04-07 Inserm Bipotential liver cell lines from wild-type mammalian liver tissue
CN101550406B (zh) * 2008-04-03 2016-02-10 北京大学 制备多潜能干细胞的方法,试剂盒及用途

Also Published As

Publication number Publication date
CN103396989A (zh) 2013-11-20
PL1888742T3 (pl) 2011-04-29
ATE486126T1 (de) 2010-11-15
JP2008541717A (ja) 2008-11-27
BRPI0613375B1 (pt) 2021-07-27
CA2609523A1 (en) 2006-11-30
DE602006017833D1 (de) 2010-12-09
BRPI0613375A2 (pt) 2011-01-11
CA2609523C (en) 2015-01-06
JP5144505B2 (ja) 2013-02-13
WO2006126236A1 (en) 2006-11-30
CN101228266A (zh) 2008-07-23
US20100003752A1 (en) 2010-01-07
WO2006126219A8 (en) 2007-02-08
CN101228266B (zh) 2015-07-29
EP1888742A1 (en) 2008-02-20
WO2006126219A1 (en) 2006-11-30
EP1888742B1 (en) 2010-10-27
US9334479B2 (en) 2016-05-10
ES2355327T3 (es) 2011-03-24

Similar Documents

Publication Publication Date Title
DK1888742T3 (da) Leverstamceller
PH12018500672A1 (en) Differentation of human embryonic stem cells
WO2006050330A3 (en) Platelets from stem cells
IL194828A (en) A method for culturing pluripotent stem cells in culture to produce endoderm and pancreatic lineage cells
WO2012030539A3 (en) Differentiation of human embryonic stem cells
SG169324A1 (en) Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
MX349178B (es) Diferenciación de células madre embrionarias humanas al linaje endocrino pancreático.
WO2011149762A3 (en) Method of nociceptor differentiation of human embryonic stem cells and uses thereof
MY159971A (en) Multipotent/pluripotent cells and methods
DK1147179T3 (da) Humane lever-progenitorer
GB2428044A (en) Method of forming mesenchymal stem cells from embryonic stem cells
RU2010107181A (ru) Дифференцировка плюрипотентных стволовых клеток с использованием питающих клеток человека
WO2012030538A3 (en) Differentiation of human embryonic stem cells
ATE548447T1 (de) Menschlicher hepatische vorläuferzellen und verfahren zur verwendung davon
MX352337B (es) Factor de reprogramacion nuclear.
WO2005097977A3 (en) Differentiation of stem cells to endoderm and pancreatic lineage
EP2504425A4 (en) DIFFERENTIATION OF HUMAN EMBRYONIC AND INDUCED PLURIPOTENTER STEM CELLS
WO2010042669A3 (en) Co-culture compositions and methods
MX2012000899A (es) Diferenciacion de celulas madre embrionarias humanas.
BR112012020958A2 (pt) "meio de cultura para a criação e/ou diferenciação de células da linhagem hemapo
WO2007062243A3 (en) Serum-free expansion of cells in culture
MY146352A (en) Adipose derived adult stem cells in hepatic regeneration
NZ622427A (en) Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same
IL186228A0 (en) Preparation of autologous haematopoietic stem cells, the methods of production, cryopreservation and use for therapy of traumatic diseases of the central nervous system
WO2005033294A3 (en) Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage